Israeli venture capital firm OTV has raised $170 million for its latest fund, with a focus on supporting digital health companies that are rapidly expanding.
The focus is on supporting companies reaching maturity and help in refine execution, tackle regulatory hurdles and help ensure a global imprint on validated products. OTV’s current portfolio includes digital health leaders such as TytoCare, Lemonaid Health, Emedgene, Scopio and Donisi Health.
"OTV's goal for the upcoming period is to harness our expertise in facilitating the growth of digital health companies, and, with laser sharp focus, identify the . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
